Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks Down Amid Covid-19 Resurgence In Europe

Mon, 26th Oct 2020 12:08

(Alliance News) - Stocks in London were recovering from steep morning losses at midday on Monday as investors weighed a rise in coronavirus cases on the European continent against progress on a vaccine.

Equity markets in the UK and Europe fell sharply in morning trade amid a surge of coronavirus cases across the US and in mainland Europe. The new wave already had forced governments in several countries including the UK, Germany and France to reimpose tough restrictions to prevent the disease from spreading.

Spain declared a national state of emergency on Sunday to tackle a second coronavirus wave as the World Health Organization reported a third straight day of record new infections across the world.

The WHO has warned that some countries are on a "dangerous track", with too many witnessing an exponential increase in cases, and called on countries to take further action to curb the spread of the disease.

In total, the UN agency's figures showed that 465,319 cases were declared on Saturday alone, half of them in Europe.

Further, Italy has ordered the closure of theatres, cinemas and gyms and said bars and restaurants must shut early.

The FTSE 100 index was down 5.25 points, or 0.1%, at 5,855.03. The FTSE 250 was down 31.35 points, or 0.2%, at 18,078.22. The AIM All-Share was up 3.07 points, or 0.3%, at 983.52.

The Cboe UK 100 was up 0.1% at 582.68, the Cboe 250 was flat at 15,333.56, and the Cboe Small Companies was up 0.6% at 9,720.09.

In Paris, the CAC 40 was down 0.7%, while the DAX 30 in Frankfurt was down 2.1%.

"While we are seeing nations attempt to stifle the spread of the virus through more localised and tentative restrictions, it seems highly likely that we will eventually see a swathe of nationwide lockdowns if the trajectory cannot be reversed. With travel stocks such as TUI and Carnival getting hit in early trade, it is clear that traders are preparing for a raft of more restrictive measures," said IG Group's Josh Mahony.

"Despite the rise in Covid cases, traders remain torn as they weigh up the potential impending benefits of a US stimulus package and potential vaccine. The latest update from Oxford highlighted how their early trials show a positive reaction to the vaccine for the elderly, with an immune response for those at most risk likely to prove a key cornerstone for any worthy vaccine candidate," Mahony added.

AstraZeneca was up 1.2% after the Anglo-Swedish drugmaker late Friday said clinical trials for its AZD1222 coronavirus vaccine, being developed alongside Oxford University, has been resumed around the world, as regulators in the US, UK, Brazil, South Africa and Japan confirmed that it is safe to do so.

The US Food & Drug Administration authorised the restart of the trials in the US, as they resumed in other countries in recent weeks, following the review of all safety data from trials in other regions.

The biggest riser in the FTSE 100, however, was Pearson. The education publisher was up 4.1%, after UBS upgraded the stock to Buy from Neutral, Pearson's US Higher Education business can hold the key to substantial growth in earnings going forward.

At the other end of the large caps, Royal Dutch Shell 'A' and 'B' shares were down 1.1% and 0.9%, respectively, tracking spot oil prices lower.

Brent oil was trading at USD40.98 a barrel on Monday at midday, down sharply from USD42.25 late Friday.

Warring factions in Libya signed a countrywide ceasefire on Friday brokered by the United Nations. The ceasefire is poised to lead to more Libyan oil supply to the market at a time when demand is weak.

In the FTSE 250, Anglo-German travel company Tui was the worst performer, down 5.8%, and cruise line operator Carnival was down 2.5% on fresh worries over Covid-19 travel restrictions.

Elsewhere, THG Group was up 13% after the online retailing platform raised its revenue guidance for 2020, following strong trading in the third quarter and continued momentum in the fourth quarter to date.

THG said that, for the three months to the end of September, total revenue grew by 39% year-on-year to GBP378.1 million. For the first nine months of 2020, revenue increased by 37% to GBP1.05 billion.

THG listed in London last month with a market capitalisation of GBP5.40 billion and at the time guided for annual revenue of GBP1.43 billion.

However, as a result of the stronger quarterly performance, the group now expects revenue to be between GBP1.48 billion to GBP1.52 billion, reflecting a 30% to 33% increase from GBP1.14 billion the year before.

The pound was quoted at USD1.3057 Monday at midday, flat from USD1.3050 at the London equities close Friday.

The euro was priced at USD1.1828, lower from USD1.1840. Against the yen, the dollar was trading at JPY104.87, marginally up from JPY104.80.

Elsewhere in commodities, gold was quoted at USD1,897.25 an ounce, down from USD1,900.50 late Friday.

US stock market futures were pointed lower as coronavirus infections in the US surged, while negotiations for a fiscal stimulus package before next week's election continue.

The Dow Jones Industrial Average was called down 0.9%, the S&P 500 down 0.8% and the Nasdaq Composite down 0.6%.

In the US, a record of nearly 80,000 new Covid-19 infections over the course of a day were reported on Friday, according to figures from Johns Hopkins University.

The virus has now claimed the lives of 1.1 million people and infected more than 42 million globally.

Meanwhile, China on Monday announced sanctions on US arms dealers, days after Washington approved the sale of weapons worth USD1 billion to Taiwan.

The sanctioned companies include Lockheed Martin, Boeing and Raytheon Technologies, according to Chinese Foreign Ministry spokesman Zhao Lijian. Zhao didn't detail the sanctions.

In the New York pre-market Monday, Boeing was down 1.9% and Raytheon down 1.5%. Lockheed Martin wasn't quoted in the pre-market session.

The move comes after the US on Wednesday approved the sale of three weapons systems worth just over USD1 billion to Taiwan, which Beijing sees as a breakaway province.

Ahead, US earnings season kicks into high gear this week with Microsoft, Pfizer, Merck, 3M and Caterpillar reporting on Tuesday, along with Visa, PayPal, Boeing, General Electric, eBay, Ford on Wednesday.

Tech companies Apple, Amazon, Alphabet and Facebook report on Thursday, while oil majors Chevron and ExxonMobil deliver earnings on Friday.

"The FANGs have been the primary drivers of the rebound in stocks, and their profit picture as well as forward guidance will be crucial to any further rally in the indices. If the high tech darlings fail to meet the expectations of investors the market could set up for a vicious downward slide as investors will face risk from Covid lockdowns, lack of fiscal stimulus, and peak growth in work from home stocks," analysts at BK Asset Management said.

The economic events calendar on Monday has US new home sales at 1500 GMT.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.